337 related articles for article (PubMed ID: 29844119)
21. Silencing of MUC20 suppresses the malignant character of pancreatic ductal adenocarcinoma cells through inhibition of the HGF/MET pathway.
Chen ST; Kuo TC; Liao YY; Lin MC; Tien YW; Huang MC
Oncogene; 2018 Nov; 37(46):6041-6053. PubMed ID: 29993037
[TBL] [Abstract][Full Text] [Related]
22. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
[TBL] [Abstract][Full Text] [Related]
23. Dynamic profiling of immune microenvironment during pancreatic cancer development suggests early intervention and combination strategy of immunotherapy.
Yang J; Zhang Q; Wang J; Lou Y; Hong Z; Wei S; Sun K; Wang J; Chen Y; Sheng J; Su W; Bai X; Liang T
EBioMedicine; 2022 Apr; 78():103958. PubMed ID: 35316682
[TBL] [Abstract][Full Text] [Related]
24. KLF10 loss in the pancreas provokes activation of SDF-1 and induces distant metastases of pancreatic ductal adenocarcinoma in the Kras
Weng CC; Hawse JR; Subramaniam M; Chang VHS; Yu WCY; Hung WC; Chen LT; Cheng KH
Oncogene; 2017 Sep; 36(39):5532-5543. PubMed ID: 28581520
[TBL] [Abstract][Full Text] [Related]
25. Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer.
Blair AB; Kim VM; Muth ST; Saung MT; Lokker N; Blouw B; Armstrong TD; Jaffee EM; Tsujikawa T; Coussens LM; He J; Burkhart RA; Wolfgang CL; Zheng L
Clin Cancer Res; 2019 Sep; 25(17):5351-5363. PubMed ID: 31186314
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of gamma-secretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma.
Plentz R; Park JS; Rhim AD; Abravanel D; Hezel AF; Sharma SV; Gurumurthy S; Deshpande V; Kenific C; Settleman J; Majumder PK; Stanger BZ; Bardeesy N
Gastroenterology; 2009 May; 136(5):1741-9.e6. PubMed ID: 19208345
[TBL] [Abstract][Full Text] [Related]
27. Regulation of pancreatic stellate cell activation by Notch3.
Song H; Zhang Y
BMC Cancer; 2018 Jan; 18(1):36. PubMed ID: 29304760
[TBL] [Abstract][Full Text] [Related]
28. Chronic inflammation initiates multiple forms of K-Ras-independent mouse pancreatic cancer in the absence of TP53.
Swidnicka-Siergiejko AK; Gomez-Chou SB; Cruz-Monserrate Z; Deng D; Liu Y; Huang H; Ji B; Azizian N; Daniluk J; Lu W; Wang H; Maitra A; Logsdon CD
Oncogene; 2017 Jun; 36(22):3149-3158. PubMed ID: 27991926
[TBL] [Abstract][Full Text] [Related]
29. Rho guanine nucleotide exchange factor ARHGEF10 is a putative tumor suppressor in pancreatic ductal adenocarcinoma.
Joseph J; Radulovich N; Wang T; Raghavan V; Zhu CQ; Tsao MS
Oncogene; 2020 Jan; 39(2):308-321. PubMed ID: 31477830
[TBL] [Abstract][Full Text] [Related]
30. Zeb1 in Stromal Myofibroblasts Promotes
Sangrador I; Molero X; Campbell F; Franch-Expósito S; Rovira-Rigau M; Samper E; Domínguez-Fraile M; Fillat C; Castells A; Vaquero EC
Cancer Res; 2018 May; 78(10):2624-2637. PubMed ID: 29490942
[TBL] [Abstract][Full Text] [Related]
31. SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells.
Wuebben EL; Wilder PJ; Cox JL; Grunkemeyer JA; Caffrey T; Hollingsworth MA; Rizzino A
Oncotarget; 2016 Jun; 7(23):34890-906. PubMed ID: 27145457
[TBL] [Abstract][Full Text] [Related]
32. IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcinoma through the STAT3 pathway.
Sun L; Zhang X; Song Q; Liu L; Forbes E; Tian W; Zhang Z; Kang Y; Wang H; Fleming JB; Pasche BC; Zhang W
Cancer Lett; 2021 Mar; 500():132-146. PubMed ID: 33309859
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of RET induces perineurial invasion of pancreatic adenocarcinoma.
Amit M; Na'ara S; Leider-Trejo L; Binenbaum Y; Kulish N; Fridman E; Shabtai-Orbach A; Wong RJ; Gil Z
Oncogene; 2017 Jun; 36(23):3232-3239. PubMed ID: 28092668
[TBL] [Abstract][Full Text] [Related]
34. [Epithelial-stromal interactions in pancreatic adenocarcinoma: the role of stroma in disease progression].
Kuznetsova AV; Popova OP; Astakhov DA; Ivanov YV; Panchenkov DN; Ivanov AA
Arkh Patol; 2022; 84(5):65-70. PubMed ID: 36178225
[TBL] [Abstract][Full Text] [Related]
35. Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.
Hossain F; Majumder S; Ucar DA; Rodriguez PC; Golde TE; Minter LM; Osborne BA; Miele L
Front Immunol; 2018; 9():1288. PubMed ID: 29915603
[TBL] [Abstract][Full Text] [Related]
36. Activation of Notch signaling in tumorigenesis of experimental pancreatic cancer induced by dimethylbenzanthracene in mice.
Kimura K; Satoh K; Kanno A; Hamada S; Hirota M; Endoh M; Masamune A; Shimosegawa T
Cancer Sci; 2007 Feb; 98(2):155-62. PubMed ID: 17297654
[TBL] [Abstract][Full Text] [Related]
37. Krüppel-like factor 10 modulates stem cell phenotypes of pancreatic adenocarcinoma by transcriptionally regulating notch receptors.
Tsai YC; Cheng KH; Jiang SS; Hawse JR; Chuang SE; Chen SL; Huang TS; Ch'ang HJ
J Biomed Sci; 2023 Jun; 30(1):39. PubMed ID: 37308977
[TBL] [Abstract][Full Text] [Related]
38. Defining the spatial distribution of extracellular adenosine revealed a myeloid-dependent immunosuppressive microenvironment in pancreatic ductal adenocarcinoma.
Graziano V; Dannhorn A; Hulme H; Williamson K; Buckley H; Karim SA; Wilson M; Lee SY; Kaistha BP; Islam S; Thaventhiran JED; Richards FM; Goodwin R; Brais R; Morton JP; Dovedi SJ; Schuller AG; Eyles J; Jodrell DI
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37553182
[TBL] [Abstract][Full Text] [Related]
39. Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma.
Kalbasi A; Komar C; Tooker GM; Liu M; Lee JW; Gladney WL; Ben-Josef E; Beatty GL
Clin Cancer Res; 2017 Jan; 23(1):137-148. PubMed ID: 27354473
[TBL] [Abstract][Full Text] [Related]
40. Higher notch expression implies poor survival in pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.
Ye J; Wen J; Ning Y; Li Y
Pancreatology; 2018 Dec; 18(8):954-961. PubMed ID: 30297095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]